Bright Uro
Latest round
- Seed
Last raised
- Jun 2022
Total raised
- $4M
Investors
- 1
About Bright Uro
Established in 2021 and based in California, US, Bright Uro, Inc. operates as a medical device company that focuses on providing diagnostic devices specifically designed for urology. In October 2024, Bright Uro, Inc. Bright Uro, Inc. specializes in developing diagnostic devices that aim to enhance the treatment of urological conditions. The company's device offers precise, comfortable, and efficient tools for diagnosing lower urinary tract conditions, resulting in improved recovery for patients. The company’s investigational Glean Urodynamics System is designed to enable wireless, catheter-free urodynamics monitoring, with the ultimate goal of improving patient comfort and clinical outcomes.
Who invested in Bright Uro
1 investor across 1 round
See all investors in Bright Uro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 9, 2022
Amount
$4M
Investors
Questions about Bright Uro
Who invested in Bright Uro?
Bright Uro has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bright Uro raised?
Bright Uro has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bright Uro last raise money?
Bright Uro's most recent round on record is a Seed, in Jun 2022.
What does Bright Uro do?
Established in 2021 and based in California, US, Bright Uro, Inc.
Where is Bright Uro headquartered?
Bright Uro is headquartered in Irvine, US.
Which VCs invest in companies like Bright Uro?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Bright Uro's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Bright Uro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.